Regeneron Pharmaceuticals
Latest Regeneron Pharmaceuticals News
-
Chasing past stock winners is usually a recipe for disaster
vs. the performance from April 10, 2011, to Dec. 31, 2011 (based on data from S&P Capital IQ): • Regeneron Pharmaceuticals regn : 257% vs. -53% • Select Comfort scss : 246% vs. -31% • Liquidity Services lqdt : 245% vs. -24
-
FDA Panel Unanimously Backs Regeneron Eye Drug
approved, Regeneron 's injectable approved, Regeneron and its partner brand name Eylea . Analysts expectations for Regeneron 's drug because Y.-based Regeneron Pharmaceuticals Inc . were halted
-
Scotts Miracle-Gro, Korn/Ferry Are Big Movers
accessories and housewares at closeout prices lowered its fiscal full-year earnings and revenue forecasts. Regeneron Pharmaceuticals Inc ., up $2.79 at $57.82 Federal regulators said the biotech drugmaker's experimental eye drug works
-
Arcalyst Treats Rare Inflammatory Disorders
joint pain, rashes and fever. One of them can also cause hearing loss and deafness. Arcalyst, made by Regeneron Pharmaceuticals Inc . of Tarrytown, N.Y., works by blocking a protein that can trigger inflammation. Respiratory infections
-
Health Highlights: Feb. 28, 2008
joint pain, rashes and fever. One of them can also cause hearing loss and deafness. Arcalyst, made by Regeneron Pharmaceuticals Inc . of Tarrytown, N.Y., works by blocking a protein that can trigger inflammation. Respiratory infections
